Ask about BPC-157

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

BPC-157

Also known as: Body Protection Compound 157

Healing Research Compound

Synthetic peptide derived from gastric juice protein

Mechanism of Action

May promote angiogenesis, tissue healing, and modulate nitric oxide pathways. Research is primarily preclinical.

BPC-157 (Body Protection Compound 157) is a synthetic peptide derived from gastric juice protein with 56 research articles and 14 clinical trials indexed — yet it remains unapproved for human use by the FDA. Preclinical data suggests it may promote angiogenesis, tissue healing, and nitric oxide pathway modulation. Its use is banned in professional sports despite growing clinical and athletic interest, according to a 2025 systematic review in HSS Journal.

1,194
Community Posts
438
Users Discussing
57
Research Articles
15
Clinical Trials

Reported Outcomes

Clinical grade reflects published research; Community grade reflects user reports (n=1,194).

Skin Health

Improvements in skin quality, firmness, and appearance

Clinical: B
Community: B
38% (374)
Joint Health

Joint pain relief and mobility improvements

Clinical: C
Community: B
37% (428)

A retrospective observation of human patients indicated that intra-articular injection of BPC-157 provided relief for chronic knee pain in the majority of subjects.

Injury Recovery

Accelerated recovery from injuries and surgery

Clinical: A
Community: B
36% (280)

Systematic reviews of preclinical studies demonstrate BPC-157 promotes recovery in muscle, tendon, ligament, and bone injuries. It accelerates functional recovery in spinal cord injury and heals corneal abrasions.

Sleep Quality

Effects on sleep quality

Clinical: B
Community: B
23% (152)
Inflammation

Reduction in inflammation and swelling

Clinical: B
Community: A
17% (98)

The peptide reduces inflammatory cytokines and demonstrates anti-inflammatory effects in incisional pain models and NSAID-induced toxicity.

Tendon & Ligament

Tendon and ligament repair and health

Clinical: A
Community: B
16% (126)

BPC-157 therapy facilitates the reattachment of muscle to bone and heals transected myotendinous junctions in rats, restoring functional biomechanics.

Wound Healing

Wound healing and scar improvement

Clinical: A
Community: B
14% (78)

BPC-157 accelerates the healing of skin wounds, deep burns, and complex fistulas (e.g., vesicovaginal) in rats, often closing defects that fail to heal spontaneously.

Anti-Aging

Anti-aging and regenerative effects

Clinical: B
Community: B
10% (56)
Energy Levels

Changes in energy and fatigue levels

Clinical: D
Community: A
9% (45)
Mental/Mood

Effects on mood and cognitive function

Clinical: C
Community: B
9% (53)

In rat models, BPC-157 counteracts cognitive dysfunction, anhedonia, and social withdrawal resembling schizophrenia symptoms. It also demonstrates anxiolytic and antidepressant effects.

Muscle Repair

Muscle recovery and repair from exercise or injury

Clinical: A
Community: A
4% (20)

BPC-157 restores myotendinous junctions and promotes muscle reattachment in rats. It also counteracts muscle wasting (cachexia) associated with tumor models.

Gut Healing

Gut lining repair and digestive health

Clinical: A
Community: B
4% (21)

Extensive preclinical evidence shows BPC-157 heals gastric ulcers, intestinal anastomoses, and ischemic colitis. It counteracts lesions from alcohol and NSAIDs (celecoxib, aspirin) and rescues sphincter function.

Hair Growth

Effects on hair growth and quality

Clinical: D
Community: A
3% (14)

Who Discusses BPC-157

From community reports with demographic data.

Gender

Male 76%
Female 24%

n=123

Age Distribution (limited data)

48
median age
range: 21-71
<30
30s
40s
50s
60+

n=55

Side Effects

Limited data

Based on 23 user reports (n=23). Frequency indicates how often each was mentioned.

Uncommon (1-5%)

Depression
Mild 2 reports 4.9%
Pain At Injection Site (Pip)
Mild 1 reports 2.4%
Red Welt That Itches
Mild 1 reports 2.4%
Injection Site Reaction (Isr)
Mild 1 reports 2.4%
Sting
Mild 1 reports 2.4%
Irritation (Related To Ghkcu Amount)
Mild 1 reports 2.4%
Stinging Upon Injection
Mild 1 reports 2.4%

Risks & Warnings

Important safety considerations based on clinical data and community reports.

!

Psychiatric Effects

8 mentions

Monitor for mood changes. Report any concerning psychiatric symptoms to healthcare provider.

i

Injection Pain/Stinging

213 mentions

Users report less sting with more dilution and slower injection; light massage can help.

i

Injection Site Reactions

96 mentions

Local reactions are common and usually mild. Rotate injection sites.

Dosing

Standard Protocol

Starting Dose
250-500mcg daily
Titration
No established protocol
Half-life
Unknown in humans
Administration
Subcutaneous injection or oral

Community Dosing Patterns

Based on 179 mentions

Community-reported patterns, not medical advice.

500mcg daily
24
daily
11
1mg daily
10
250mcg daily
6
500mcg
4

Pricing

Research-grade reference pricing for 10mg vial. Prices vary by vendor and quantity. Research chemicals require self-mixing and lack medical oversight. Shipping is not included.

We do not list vendors. Prices are aggregated from community reports and should be treated as rough ranges.

US Research Grade

$65

Single small vial from US domestic vendors

US Research (Bulk)

$50.9

Per-dose equivalent when buying larger US vials

China Research

$6.8

Per-vial when buying 10-pack from Chinese vendors

Research

57
Total Articles
15
Clinical Trials
18
Reviews

Key Studies

Commonly Stacked With

From community members' documented stacks involving BPC-157.

TB-500 259 stacks (71.3%)
GHK-Cu 147 stacks (40.5%)
Retatrutide 84 stacks (23.1%)
KPV 72 stacks (19.8%)
Tirzepatide 64 stacks (17.6%)

Switching Patterns

Based on 84 discussions about switching to or from BPC-157.

Switching FROM

Retatrutide 14 mentions
Tirzepatide 7 mentions
GHK-Cu 6 mentions
Cagrilintide 5 mentions

Users who switched to BPC-157

Switching TO

KPV 9 mentions
GHK-Cu 8 mentions
Retatrutide 7 mentions
TB-500 7 mentions

Users who switched from BPC-157

Related Guides